Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination

Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination

We evaluated the post-vaccination humoral response of three real-world cohorts. Vaccinated subjects primed with ChAdOx1-S and boosted with BNT162b2 mRNA vaccine were compared to homologous dosing (BNT162b2/BNT162b2 and ChAdOx1-S/ChAdOx1-S). Serum samples were collected two months after vaccination f...

Full description

Bibliographic Details
Main Authors: Simone Barocci, Chiara Orlandi, Aurora Diotallevi, Gloria Buffi, Marcello Ceccarelli, Daniela Vandini, Eugenio Carlotti, Luca Galluzzi, Marco Bruno Luigi Rocchi, Mauro Magnani, Anna Casabianca
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Vaccines
Subjects:
SARS-CoV-2
COVID-19
heterologous vaccination
anti-S antibodies
IgG anti-S response
Online Access:https://www.mdpi.com/2076-393X/10/4/491

Internet

https://www.mdpi.com/2076-393X/10/4/491

Similar Items